Endothelin and erectile dysfunction: a target for pharmacological intervention?

Bibliography

• HANSON-DIVERS C, JACKSON SE, LUE TE et al: Health outcomes variables important to patients in the treat-ment of erectile dysfunction. J. Urol. (1998) 159: 1541–1547.
   PubMed Web of Science ®Google Scholar
• FELDMAN HA, GOLDSTEIN I, HATZICHRISTOU DG et al.: Impotence and its medical and psychosocial corre-lates: results of the Massachusetts Male Ageing Study. J. Urol. (1994) 151:54–61.
   PubMed Web of Science ®Google Scholar
• ZEMEL P: Sexual dysfunction in the diabetic patient with hypertension. Am. J. Cardiol. (1988) 61:27-33H.
   Google Scholar
• RUBIN A, ABBOT D: Impotence and diabetes mellitus. JAMA (1958) 168:498.
   PubMed Web of Science ®Google Scholar
• NIH CONSENSUS CONFERENCE: Impotence. NIH Con-sensus Development Panel on Impotence. JAMA. (1993) 270:83–90.
   Google Scholar
• FURLOW WL: Prevalence of impotence in the United States. Med. Aspects Hum. Sex. (1985) 19:13.
   Google Scholar
• SHABSIGH R, FISHMAN IJ, SCOTT FB: Evaluation of erec-tile impotence. Urology (1988) 32:83–90.
   PubMed Web of Science ®Google Scholar
• NELSON C, MCLEMORE T: The National Ambulatory Medical Care Survey: United States, 1975–81 and 1985 trends. Vital and health statistics. Series 13. No. 93. Washington, DC: Government Printing Office (1988) DHHS publication no. (PHS) 88–1754.
   Google Scholar
• National Center for Health Statistics. National HospitalDischarge Survey, 1985. Bethesda, MD: Department of Health and Human Services. (1989). DHHS publication no. 87–1751.
   Google Scholar
• VIRAG R BECK-ARCHLLY L: Nosology, epidemiology, clinical quantification of erectile dysfunction. Revue de Medecine Interne (1997) (Suppl. 1):10s–13s.
   Google Scholar
• GOLDMEIER D, KEANE FE, CARTER P et al.: Prevalence of sexual dysfunction in heterosexual patients attending a central London genitourinary medicine clinic. Int. J. STD AIDS (1997) 8:303–306.
   PubMed Web of Science ®Google Scholar
• READ S, KING M, WATSON J: Sexual dysfunction in pri-mary care: prevalence, characteristics and detection by the general practitioner. J. Pub. Health Med. (1997) 19:387–391.
   PubMedGoogle Scholar
• WAGNER G, SAENZ DE TEJADA I: Update on male erec-tile dysfunction. BMJ (1998) 316:678–682.
   PubMed Web of Science ®Google Scholar
• ANDERSSON K-E, WAGNER G: Physiology of penile erection. Physiol. Rev. (1995) 75:191–236.
   PubMed Web of Science ®Google Scholar
• LERNER SE, MELMAN A, CHRIST GJ: A review of erectile dysfunction: new insights and more questions. J. Urol. (1993) 149:1246–1255.
   PubMed Web of Science ®Google Scholar
• TAUB HC, LERNER SE, MELMAN A, CHRIST GJ: Relation-ship between contraction and relaxation in human and rabbit corpus cavernosum. Urology (1993) 42:698–704.
   PubMed Web of Science ®Google Scholar
• DAIL WG, MANZANARES K, MOLL MA, MINORSKY N: Thehypogastric nerve innervates a population of penile neurons in the pelvic plexus. Neuroscience (1985) 16:1041–1046.
   PubMed Web of Science ®Google Scholar
• DORR LD, BRODY MJ: Hemodynamic mechanisms oferection in the canine penis. Am. J. Physic)]. (1967) 213:1526–1531.
   PubMed Web of Science ®Google Scholar
• SIROKY MB, KRANE RJ: Neurophysiology of erection. In: Male sexual Dysfunction. Krane RJ, Siroky MB, Goldstein (Eds.), Little, Brown, Boston, MA (1983).
   Google Scholar
• SAENZ DE TEJADA I, BLANCO R et al: Cholinergic neuro-transmission in human corpus cavernosum. I. Re-sponses of isolated tissue. Am. J. Physic)]. (1988) 254:H459–H467.
   PubMed Web of Science ®Google Scholar
• SAENZ DE TEJADA I, GOLDSTEIN I et al: Impaired neu-rogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impo-tence. New Eng]. J. Med. (1989) 320:1025–30.
   PubMed Web of Science ®Google Scholar
• SAENZ DE TEJADA I: Mechanisms for the regulation of penile smooth muscle contractility. In: World Book of Impotence. Lue T (Ed.), Smith Gordon/Nishimura, London. (1992):264–292.
   Google Scholar
• LUGG JA, GONZALEZ-CADAVID NF, RAJFER J: The role ofnitric oxide in erectile function. J. Androl. (1995) 16:2–4.
   PubMed Web of Science ®Google Scholar
• RAJFER J, ARONSON WJ, BUSH P et al. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neuro- transmission. New Engl. J. Med. (1992) 326:90–94.
   PubMed Web of Science ®Google Scholar
• BURNETT AL, LOWENSTEIN CJ, BREDT D et al: Nitric ox-ide: a physiologic mediator of penile erection. Science (1992) 257:401–403.
   PubMed Web of Science ®Google Scholar
• FORSTERMANN U, CLOSS El, POLLOCK JS et al.: Nitric ox-ide isozymes. Characterization, purification, molecu-lar cloning and functions. Hypertension (1994) 23:1121–1131.
   Google Scholar
• FURCHGOTT RF, ZAWADZKI JV: The obligatory role ofendothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 288:373–376.
   PubMed Web of Science ®Google Scholar
• IGNARRO LJ, BUSH PA, BUGA GM et al: Nitric oxide andcyclic GMP formation upon electrical field stimulation causes relaxation of corpus cavernosum smooth mus-cle. Biochem. Biophys. Res. Comm. (1990) 170:843–850.
   PubMed Web of Science ®Google Scholar
• YANAGISAWA M, KURIHARA H, KIMURA S et al.: A novelpotent vasoconstrictor peptide produced by vascular endothelial cells. Nature (1988) 332:411–415.
   PubMed Web of Science ®Google Scholar
• INOUE A, YANAGISAWA M, KIMURA S et al: The humanendothelin family: three structurally and pharmaco-logically distinct isopeptides predicted by three sepa-rate genes. Proc. Natl. Acad. Sci. USA (1989) 86:2863–2867.
   PubMed Web of Science ®Google Scholar
• MASAKI T, KIMURA S, YANAGISAWA M, GOTO K: Mo-lecular and cellular mechanism of endothelial regula-tion: implications for vascular function. Circulation (1991) 84:1457–1468.
   PubMed Web of Science ®Google Scholar
• MCMAHON EG, PALOMO MA, MOORE WM et al.: Phos-phoramidon blocks the pressor activity of porcine big endothelin-1 (1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin 141-21) in vitro. Proc. Natl. Acad. Sci. USA (1991) 88:703–707.
   PubMed Web of Science ®Google Scholar
• ARAI H, HORI S, ARAMORI L, OHKUBO H, NAKANISHI S:cloning and expression of cDNA encoding an endothe-lin receptor. Nature (1990) 348:370–372.
   Web of Science ®Google Scholar
• VANHOUTTE PM, RUBANYI GM, MILLER VM, HOUSTONDS: Modulation of vascular smooth muscle contraction by the endothelium. Annu. Rev. Physiol. (1986) 48:307–320.
   PubMed Web of Science ®Google Scholar
• TAYLOR SG, WESTON AH: Endothelium-derived hyper-polarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci. (1988) 9:272–274.
   PubMed Web of Science ®Google Scholar
• SAENZ DE TEJADA I, CARSON MP, GOLDSTEIN I, TRAISHAM: Endothelin: localization, synthesis, activity and receptor types in human penile corpus cavernosum. Am. J. Physiol. (1991) 261:H1078–H1085.
   PubMed Web of Science ®Google Scholar
• LERNER SE, VALCIC M, GONDRE M et al.: Endothelin as aputative modulator of erectile dysfunction. J. Urol. (1993) 149:285A.
   Google Scholar
• CHRIST GJ, LERNER SE, KIM DC, MELMAN A: Endothelinas a putative modulator of erectile physiology and dys-function. I. Characteristics of ET-1-induced contrac-tions in isolated corporal smooth muscle strips. J. Urol. (1995) 153:1998–2003.
   Google Scholar
• LAU LC, ADAIKEN PG, RATNAM SS: Effects ofendothelin-1 on the human corpus cavernosum and penile vasculature. Asia Pacific J. Pharmacol. (1991) 6:287.
   Google Scholar
• HOLMQUIST F, KIRKEBY HJ, LARSSON B etal.: Functional effects, binding sites and immunolocalization of endothelin-1 in isolated penile tissues from man and rabbit. J. Pharmacol Exp. Ther. (1992) 261:795–802.
   Google Scholar
• GOTO K, KASUYA Y, MATSUKI N et al.: Endothelin acti-vates the dihydropyridine-sensitive, voltage-dependent Ca2+ channel in vascular smooth muscle. Proc. Natl. Acad. Sci. USA (1989) 86:3915–3918.
   PubMed Web of Science ®Google Scholar
• MARSDEN PA, DANTHULURI NR, BRENNER BM et al: En-dothelin action on vascular smooth muscle involves inositol triphosphate and calcium mobilization. Bio-chem. Biophys. Res. Commun. (1989) 158:86–93.
   PubMed Web of Science ®Google Scholar
• BERRIDGE MJ: Inositol trisphosphate and diacylglyc-erol: two interacting second messangers. Ann. Rev. Bio-chem. (1987) 56:159–93.
   PubMed Web of Science ®Google Scholar
• RASMUSSEN H, TAKUWA Y, PARK S: Protein kinase C in the regulation of smooth muscle contraction. FASEBJ. (1987) 1:177–185.
   PubMed Web of Science ®Google Scholar
• ZHAO W, CHRIST GJ: Endothelin-1 as a putative modu-lator of erectile dusfunction. II. Calcium mobilization in cultured human corporal smooth muscle cells. J. Urol. (1995) 154:1571–1579.
   Google Scholar
• SOMLYO AP, SOMLYO AV: Signal transduction and regulation in smooth muscle. Nature (1994) 372:231–236.
   PubMed Web of Science ®Google Scholar
• STEERS WD: Smooth muscle physiology. A UA Update Se-ries (1994) 30:238.
   Google Scholar
• KARAKI H: Ca2+ regulation of vascular smooth muscle and release of endothelin-derived relaxing factor. In: Ion Channels of Vascular Smooth Muscle and Endothelial Cells. Sperelakis N, Kuriyama H (Eds.), Elsevier Press, New York, USA (1990:297–315.
   Google Scholar
• KITAZAWA T, SOMLYO AP: Modulation of Ca2+ sensitiv-ity by agonists in smooth muscle. In: Regulation of Smooth Muscle Contraction. Moreland RS (Ed.), Plenum Press, New York (1991):97–109.
   Google Scholar
• NISHIMURA J, MORELAND S, MORELAND RS, VAN BREE-MAN C: regulation of the Ca2+ force relationship in per-meabilized arterial smooth muscle. In: Regulation of Smooth Muscle Contraction. Moreland RS (Ed.), Plenum Press, New York (1990:111–127.
   Google Scholar
• SAENZ DE TEJADA I, CARSON MP, TRAISH A et al.: Role of endothelin, a new vasoconstrictor peptide, in the local control of penile smooth muscle. J. Urol. (1989) 141:222.
   Google Scholar
• HOLMQUIST F, ANDERSSON K-E, HEDLUND H: Actions of endothelin on isolated corpus cavernosum from rabbit and man. Acta. Physiol. Scand. (1990) 13:113–122.
   Google Scholar
• VICKERS MA, SEILER M, WEIDNER N: Corpora cavernosa ultrastructure in vascular erectile dysfunction. J. Urol. (1990) 143:1131–1134.
   PubMed Web of Science ®Google Scholar
• GOLDSTEIN AMB, PADMA-NATHAN H: The microarchi-tecture of the intracavernosal smooth muscle and the cavernosal fibrous skeleton. J. Urol. (1990) 144:1144–1146.
   PubMed Web of Science ®Google Scholar
• SULLIVAN ME, MILLER MAW, BELL CRW et al: The effects of cigarette smoking on vascular risk factors in pa-tients with erectile dysfunction. Eur. Urol. (1996) 30:250.
   Google Scholar
• SULLIVAN ME, MILLER MAW, BELL CRW et al.: Does sever-ity of ischaemic coronary disease correlate with erec-tile dysfunction? Int. J. Imp. Res. (1998) 10:75.
   PubMed Web of Science ®Google Scholar
• MULLER SC, EL-DAMANHOURY H, RUTH J, LUE TF: Hy-pertension and impotence. Eur.Urol. (1991) 19:29–34.
   PubMed Web of Science ®Google Scholar
• VIRAG R, BOUILLY P, FRYDMAN D: Is impotence an arte-rial disorder? A study of arterial risk factors in 440 im-potent men. Lancet (1985) 1:181–184.
   PubMed Web of Science ®Google Scholar
• SHABSIGH R, FISHMAN IJ, SCHUM C, DUNN JK: Cigarette smoking and other vascular risk factors in vasculo-genic impotence. Urology (1991) 38:227–231.
   PubMed Web of Science ®Google Scholar
• RANDALL MD: Vascular activities of endothelins. Phar-macol. Ther. (1991) 50:73–93.
   PubMed Web of Science ®Google Scholar
• TABUSHI Y, NAKAMARU M, RAKUGI H et al.: Effect of en-dothelin on neuroeffector junction in mesenteric ar-teries of hypertensive rat. Hypertension (1990) 15:739–743.
   PubMed Web of Science ®Google Scholar
• YANG ZH, RICHARD V, VON SEGESSER L et al.: Thresholdconcentrations of endothelin-1 potentiate contrac-tions to norepinephrine and serotonin in human ar-teries. Circulation (1990) 82:188–195.
   Google Scholar
• ITOH H, HIRAOKA N, HIGUCHI H et al.: Contractile ac-tions of endothelin-1 in isolated helical strips from rat pulmonary artery: potentiation of serotonin-induced contraction. J. Cardiovasc. Pharmacol (1992) 20:1–6.
   PubMed Web of Science ®Google Scholar
• HENRION D, LAHER I: Potentiation of norepinephrine-induced contraction by endothelin-1 in the rabbit aorta. Hypertension (1993) 22:78–83.
   PubMed Web of Science ®Google Scholar
• KIM DC, GONDRE CM, CHRIST GJ: Endothelin-1-induced modulation of contractile responses elicited by an al-pha 1-adrenergic agonist on human corpus caverno-sum smooth muscle. Int. J. Impot. Res. (1996) 8 (1) :17–24.
   PubMedGoogle Scholar
• CHRIST GJ, MAAYANI S, VALCIC M, MELMAN A: Pharma-cological studies of human erectile tissue: characteris-tics of spontaneous contractions and alterations in alpha-adrenoceptor responsiveness with age and dis-ease in isolated tissues. Br. J. Pharmacol. (1990) 101:375–381.
   PubMed Web of Science ®Google Scholar
• CHRIST GJ, SCHWARTZ CB, STONE BA: Kinetic charac-teristics of alpha-1 adrenergic contractions in human corpus cavernosum smooth muscle. Am. J. Physiol. (1992) 263:H5–H9.
   Google Scholar
• CHRIST GJ, STONE B, MELMAN A: Age-dependent altera-tions in the efficacy of phenylephrine-induced con-tractions in the vascular smooth muscle isolated from the corpus cavernosum of impotent men. Can. J. Physiol (1991) 69:909–913.
   PubMed Web of Science ®Google Scholar
• LERMAN A, HIDEBRAND FL, MARGULIES KB: Endothelin:a new cardiovascular regulatory peptide. Mayo Clin. Proc. (1990) 65:1441–1455.
   PubMed Web of Science ®Google Scholar
• OHLSTEIN EH, DOUGLAS SA: Endothelin-1 modulatesvascular smooth muscle structure and vasomotion: implications in cardiovascular physiology. Drug. Dev. Res. (1993) 29:108.
   Web of Science ®Google Scholar
• TABUCHI Y, NAKAMURA M, RAKUGI H et al: Endothelinenhances adrenergic vasoconstriction in perfused rat mesenteric arteries. Biochem. Biophys. Res. Comm. (1989) 159:1304–1308.
   PubMed Web of Science ®Google Scholar
• DOHI Y, HAHN AW, BOULANGER CM et al.: Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension (1992) 19:131–137.
   PubMed Web of Science ®Google Scholar
• BOLGER GT, LIARD F, JODOIN A, JARAMILLO J: Vascular reactivity, tissue levels, and binding sites for endothe-lin: a comparison in the spontaneously hypertensive and Wistar Kyoto rats. Can. J. Physiol Pharmacol (1990) 69:406–413.
   Web of Science ®Google Scholar
• CRISCIONE L, THOMANN H, LAU TD: Sensitivity and re-activity to endothelin-1 in mesenteric beds and aortic rings of 4-week-old spontaneously hypertensive rats. Clin. Exper. Hypertens. (1992) 14:453–467.
   Web of Science ®Google Scholar
• TOMOBE Y, MIYAUCHI T, SAITO A et al.: Effects of endo-thelin on renal artery from spontaneously hyperten-sive and Wister-Kyoto rats. Eur. J. Pharmacol (1988) 152:373–374.
   PubMed Web of Science ®Google Scholar
• ISHIKAWA T, TOMOBE Y, YANAGISAWA M et al.: In-creased sensitivity to endothelin-1 in spontaneously hypertensive rats is closely related to resting mem-brane potential. J. Am. Coll Cardiol (1990) 15:67A.
   Google Scholar
• DOHI Y, LUSCHER TF: Endothelin in hypertensive re-sistance arteries: intramural and extraluminal dys-function. Hypertension (1991) 18:543–549.
   PubMed Web of Science ®Google Scholar
• SEMPERE AP, DUARTE J, CABEZAS C, CLAVERIA LE: Etio-pathogenesis of transient ischaemic attacks and mi-nor ischaemic strokes: a community-based study in Segovia, Spain. Stroke (1998) 29:40–45.
   PubMedGoogle Scholar
• CURB JD, MASAKI K, RODRIGUEZ et al.: Peripheral vas-cular disease and cardiovascular risk factors in the eld-erly. The Honolulu Heart Program. Arterioscl. Thromb. Vasc. Biol. (1996) 16:1495–500.
   PubMed Web of Science ®Google Scholar
• DALY RJ, BLANN AD: Self-reported smoking in vascular disease: the need for biochemical confirmation. Br. J. Biomed Sci. (1996) 53:204–208.
   PubMed Web of Science ®Google Scholar
• MANNINO DM, KLEVENS RM, FLANDERS WD: Cigarette smoking: an independent risk factor for impotence? Am. J. Epidemiol (1994) 140:1003–1008.
   Web of Science ®Google Scholar
• ROSEN MP, GREENFIELD AJ, WALKER TG: Cigarette smoking: an independent risk factor for atherosclero-sis in the hypogastric-cavernous arterial bed of men with arteriogenic impotence. J. Urol. (1991) 145:759–763.
   PubMed Web of Science ®Google Scholar
• HIRSHKOWITZ M, KARACAN I, HOWELL JW et al: Noctur-nal penile tumescence in cigarette smokers with erec-tile dysfunction. Urology (1992) 34:101–107.
   Google Scholar
• JEREMY JY, MIKHAILIDIS DP, PITTILO RM: Cigarette smoking and cardiovascular disease. J. Roy. Soc. Health (1995) 115:289–295.
   PubMedGoogle Scholar
• CHUNG SM, GAY CA, MCCRARY JA: Nonarteric ischae-mic optic neuropathy. The impact of tobacco use. Oph-thalmology (1994) 101:779–782.
   Google Scholar
• ISHII DN: Implication of insulin-like growth factors inthe pathogenesis of diabetic nephropathy. Brain Res. Rev. (1995) 20:47–67.
   PubMed Web of Science ®Google Scholar
• KIOWSKI W, UNDER L, STOSCHITSKY K et al.: Dimin-ished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation (1994) 90:27–34.
   PubMed Web of Science ®Google Scholar
• BODIS S, HAREGEWOIN A: Significantly reduced sali-vary nitric oxide levels in smokers. Ann. Oncol. (1994) 5:371–372.
   PubMed Web of Science ®Google Scholar
• KHARITONOV SA, ROBBINS RA, YATES D eta].: Acute andchronic effects of cigarette smoking on exhaled nitric oxide. Am. J. Resp. Crit. Care Med. (1995) 152:609–612.
   Google Scholar
• XIE Y, GARBAN H, NG C: Effect of long-term passivesmoking on erectile function and penile nitric oxide synthase in the rat. J. Urol. (1997) 157:1121–1126.
   PubMed Web of Science ®Google Scholar
• JEREMY JY, MIKHAILIDIS DP, DANDONA P: Muscarinicstimulation of prostacyclin synthesis by the rat penis. Eur. Pharmacol (1986) 123:67–71.
   PubMed Web of Science ®Google Scholar
• JEREMY JY, MIKHAILIDIS DP, THOMPSON CS, DANDONAP: The effect of cigarette smoke and diabetes mellitus on muscarinic stimulation of prostacyclin synthesis by the rat penis. Diab. Res. (1986) 3:467–469.
   PubMedGoogle Scholar
• JEREMY JY, THOMPSON CS, MIKHAILIDIS DP, DANDONAP: Experimental diabetes mellitus inhibits prostacy-din synthesis by the rat penis; pathological implica-tions. Diabetologia (1985) 28:365–368.
   PubMed Web of Science ®Google Scholar
• JEREMY JY, MIKHAILIDIS DP: Cigarette smoking and erectile dysfunction. J. Roy. Soc. Health (1998) 118:151–155.
   PubMedGoogle Scholar
• GOERRE S, STAEHLI C, SHAW S, LUSCHER TF: Effect ofsmoking and nicotine on plasma endothelin-1 levels. J. Cardiovasc. Pharmacol (1995) 26:S236–S238.
   PubMed Web of Science ®Google Scholar
• GLINA R, REICHELT AC, LEAO PP, DOS REIS JM: Impact ofcigarette smoking on papaverine induced erection. J. Urol. (1988) 140:523–524.
   PubMed Web of Science ®Google Scholar
• LEVINE LA, GERBER GS: Acute vasospasm of penile ar-teries in response to cigarette smoking. Urology (1990) 36:99–100.
   PubMed Web of Science ®Google Scholar
• AZADZOI KM, SAENZ DE TEJADA I: Hypercholesterolae-mia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J. Urol. (1991) 146:238–240.
   PubMed Web of Science ®Google Scholar
• KRANE RF, GOLDSTEIN I, DE TEJADA IS: Impotence. NewEngl. J. Med. (1990) 321:1648–1659.
   Web of Science ®Google Scholar
• SULLIVAN ME, DASHWOOD MR, THOMPSON CS et al.: Down-regulation of endothelin-B receptor sites in cav-ernosal tissue of hypercholesterolaemic rabbits. Br. J. Urol. (1998) 81:128–134.
   PubMedGoogle Scholar
• MCCULLOCH DK, CAMPBELL IW, WU FC et al: The preva-lence of diabetic impotence. Diabetologia (1980) 18:279–283.
   PubMed Web of Science ®Google Scholar
• RUZBARSKY V, MICHAL V: Morphologic changes in the arterial bed of the penis with ageing: relationship to the pathogenesis of impotence. Invest. Urol. (1977) 15:194–199.
   PubMedGoogle Scholar
• ABELSON D: Diagnostic value of the penile pulse and blood pressure: a Doppler study of impotence in dia-betics. J. Urol (1975) 113:636–639.
   PubMed Web of Science ®Google Scholar
• FAERMAN I, GLOCER L, FOX D et al: Impotence and dia-betes: histological studies of the autonomic nervous fi-bers of the corpora cavernosa in impotent diabetic males. Diabetes (1974) 23:424–428.
   PubMedGoogle Scholar
• FANI K, LUNDIN AP, BEYER MM: Pathology of the penis in long-term diabetic rats. Diabetologia (1983) 25:424–428.
   PubMed Web of Science ®Google Scholar
• GU J, POLAK JM, LAZARIDES M et al.: Decrease of vasoac-tive intestinal polypeptide (VIP) in the penises from impotent men. Lancet (1984) 2:315–318.
   PubMed Web of Science ®Google Scholar
• LINCOLN J, CROWE R, BLACKLAY PF et al: Changes in vi-pergic, cholinergic and adrenergic innervation of hu-man penile tissue in diabetic and non-diabetic impotent males. J. Urol. (1987) 137:1053–1059.
   PubMed Web of Science ®Google Scholar
• MELMAN A, HENRY DP, FELTON DL, O'CONNOR BL: Al-teration of the penile corpora in patients with erectile impotence. Invest. Urol. (1980) 17:474–477.
   PubMedGoogle Scholar
• AZADZOI KM, SAENZ DE TEJADA I: Diabetes mellitus impairs neurogenic and endothelium-mediated re-laxation of rabbit corpus cavernosum smooth muscle. Urol. (1992) 148:1587–1591.
   Web of Science ®Google Scholar
• FRANCAVILLA S, PROPERZI G, BELLINI C et al.: Endothelin-1 in diabetic and nondiabetic men with erectile dysfunction. J. Urol (1997) 158:1770–1774.
   PubMed Web of Science ®Google Scholar
• TAKAHASHI K, GHATEI MA, LAM H-C et al.: Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia (1990) 33:306–310.
   PubMed Web of Science ®Google Scholar
• SULLIVAN ME, DASHWOOD MR, THOMPSON CS eta].: Al-terations in endothelin B receptor sites in cavernosal tissue of diabetic rabbits: potential relevance to the pathogenesis of erectile dysfunction. J. Urol. (1997) 158:1966–1972.
   Google Scholar
• LERMAN A, EDWARDS BS, HALLET JAN et al: Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. New Engl. J. Merl. (1991) 325:997–1001.
   PubMed Web of Science ®Google Scholar
• GREENSTEIN A, CHEN J, MILLER H eta].: Does severity of ischaemic coronary disease correlate with erectile dysfunction? Int. J. Impot. Res. (1997) 9:123–126.
   Google Scholar
• UCHIDA Y, YOSHIMOTO N, MURAO S: Effect of 2-nicotinamidoethyl nitrate (SG-75) on coronary circu-lation. Jpn. Heart J. (1978) 6:112–124.
   Google Scholar
• TAIRA N, SATOH K, YANAGISAWA T et al.: Pharma-cological profile of a new coronary vasodilator drug, 2-nicotinamidoethyl nitrate (SG-75). Clin. Exp. Pharma-col. Physiol (1979) 6:301–316.
   PubMed Web of Science ®Google Scholar
• SAKAI K: Nicorandil: animal pharmacology. Am. J. Car-diol (1989) 63:2J–10J.
   Google Scholar
• FRAMPTON J, BUCKLEY MM, FITTON A: Nicorandil. A re-view of its pharmacology and therapeutic efficacy in angina pectoris. Drugs (1992) 44:625–655.
   Google Scholar
• HEDLUND P, HOLMQUIST F, HEDLUND H, ANDERSON K-E: Effects of nicorandil on human isolated corpus cavernosum and cavernous artery. J. Urol. (1994) 151:1107–1113.
   PubMed Web of Science ®Google Scholar
• STEWART DJ, LANGLEBEN D, CERNACEK P, CIANFIONE K: Endothelin release is inhibited by coculture of endo-thelial cells with cell of vascular media. Am. J. Physic)]. (1990) 259:H1928–H1932.
   PubMed Web of Science ®Google Scholar
• BOULANGER CM, LUSCHER TF: Release of endothelin from the porcine aorta: inhibition by the endothelium-derived nitric oxide. J. Clin. Invest. (1990) 85:587–590.
   PubMed Web of Science ®Google Scholar
• SAIJONAMAA O, RISTIMAKI A, FYHRQUIST F: Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells. Biochem. Biophys. Res. Commun. (1990) 173:514–520.
   PubMed Web of Science ®Google Scholar
• SPERELAKIS N, INOUE Y, NOZAKI M, ISHIKAWA S: Neuro-muscular transmission at adrenergic nerve terminals with vascular smooth muscle in guinea-pig mesenteric artery. In: Ion Channels of Vascular Smooth Muscle and En-dothelial Cells. Sperelakis N, Kuriyama H (Eds.), Elsevier Sci-ence Publishing Company, Inc., New York, NY (1991).
   Google Scholar